Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 6, 2009, Pages 1377-1384

  Kim, Dae Hyun ^a   Daskalakis, Constantine ^b   Silvestry, Scott C ^b   Sheth, Mital P ^c   Lee, Andrew N ^b   Adams, Suzanne ^b   Hohmann, Sam ^d   Medvedev, Sofia ^d   Whellan, David J ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Hamilton Cardiology Associates   (United States)

^d University HealthSystem Consortium   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; THROMBIN INHIBITOR;

ADULT; AGED; ARTICLE; BLEEDING; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SURGERY; DRUG SAFETY; FEMALE; HOSPITAL READMISSION; HUMAN; ISCHEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OFF PUMP CORONARY SURGERY; ON PUMP CORONARY SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; THROMBOSIS;

ADULT; ASPIRIN; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; TICLOPIDINE;

EID: 71649086309     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.07.027     Document Type: Article

References (44)

1. Ascione R., Williams S., Lloyd C.T., Sundaramoorthi T., Pitsis A.A., and Angelini G.D. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study. J Thorac Cardiovasc Surg 121 (2001) 689-696
2. Hannan E.L., Wu C., Smith C.R., Higgins R.S., Carlson R.E., Culliford A.T., et al. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation 116 (2007) 1145-1152
3. Mariani M.A., Gu Y.J., Boonstra P.W., Grandjean J.G., van O.W., and Ebels T. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate?. Ann Thorac Surg 67 (1999) 1370-1375
4. Moller C.H., and Steinbruchel D.A. Platelet function after coronary artery bypass grafting: is there a procoagulant activity after off-pump compared with on-pump surgery?. Scand Cardiovasc J 37 (2003) 149-153
5. Quigley R.L., Fried D.W., Pym J., and Highbloom R.Y. Off-pump coronary artery bypass surgery may produce a hypercoagulable patient. Heart Surg Forum 6 (2003) 94-98
6. Bybee K.A., Powell B.D., Valeti U., Rosales A.G., Kopecky S.L., Mullany C., et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 112 9 Suppl (2005) I286-I292
7. Dacey L.J., Munoz J.J., Johnson E.R., Leavitt B.J., Maloney C.T., Morton J.R., et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg 70 (2000) 1986-1990
8. Mangano D.T. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 (2002) 1309-1317
9. Zimmermann N., Kienzle P., Weber A.A., Winter J., Gams E., Schror K., et al. Aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg 121 (2001) 982-984
10. Zimmermann N., Wenk A., Kim U., Kienzle P., Weber A.A., Gams E., et al. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 108 (2003) 542-547
11. Zimmermann N., Kurt M., Wenk A., Winter J., Gams E., and Hohlfeld T. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?. Eur J Cardiothorac Surg 27 (2005) 606-610
12. Zimmermann N., Kurt M., Winter J., Gams E., Wenzel F., and Hohlfeld T. Detection and duration of aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg 135 (2008) 947-948
13. Fox K.A., Mehta S.R., Peters R., Zhao F., Lakkis N., Gersh B.J., et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 110 (2004) 1202-1208
14. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
15. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
16. Lim E., Cornelissen J., Routledge T., Kirtland S., Charman S.C., Bellm S., et al. Clopidogrel did not inhibit platelet function early after coronary bypass surgery: a prospective randomized trial. J Thorac Cardiovasc Surg 128 (2004) 432-435
17. Halkos M.E., Cooper W.A., Petersen R., Puskas J.D., Lattouf O.M., Craver J.M., et al. Early administration of clopidogrel is safe after off-pump coronary artery bypass surgery. Ann Thorac Surg 81 (2006) 815-819
18. Shennib H., Endo M., and Benhameid O. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting. Heart Surg Forum 6 (2003) 288-291
19. Gurbuz A.T., Zia A.A., Vuran A.C., Cui H., and Aytac A. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur J Cardiothorac Surg 29 (2006) 190-195
20. Chan V., Kulik A., Bourke M.E., Ressler L., Mesana T.G., and Ruel M. Clopidogrel is safe early after on- and off-pump coronary artery bypass surgery. J Card Surg 22 (2007) 493-497
21. University HealthSystem Consortium. Available at: www.uhc.edu. Accessed March 15, 2008.
22. HCUP Comorbidity Software. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. Available at: www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp. Accessed Oct 30, 2006.
23. American Hospital Association. American Hospital Association Guide: America's Directory of Hospitals and Health Care Systems (2009), AHA Press, Chicago, IL
24. Hongo R.H., Ley J., Dick S.E., and Yee R.R. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 40 (2002) 231-237
25. Mehta R.H., Roe M.T., Mulgund J., Ohman E.M., Cannon C.P., Gibler W.B., et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 48 (2006) 281-286
26. Kapetanakis E.I., Medlam D.A., Petro K.R., Haile E., Hill P.C., Dullum M.K., et al. Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?. Circulation 113 (2006) 1667-1674
27. Vaccarino G.N., Thierer J., Albertal M., Vrancic M., Piccinini F., Benzadon M., et al. Impact of preoperative clopidogrel in off pump coronary artery bypass surgery: a propensity score analysis. J Thorac Cardiovasc Surg 137 (2009) 309-313
28. Chu M.W., Wilson S.R., Novick R.J., Stitt L.W., and Quantz M.A. Does clopidogrel increase blood loss following coronary artery bypass surgery?. Ann Thorac Surg 78 (2004) 1536-1541
29. 3M Health Information Systems. Available at: http://solutions.3m.com/wps/portal/3M/en_US/3MHIS/HealthInformationSystems. Accessed Oct 28, 2006.
30. Iezzoni L.I., Ash A.S., Shwartz M., Daley J., Hughes J.S., and Mackiernan Y.D. Judging hospitals by severity-adjusted mortality rates: the influence of the severity-adjustment method. Am J Public Health 86 (1996) 1379-1387
31. Landon B., Iezzoni L.I., Ash A.S., Shwartz M., Daley J., Hughes J.S., et al. Judging hospitals by severity-adjusted mortality rates: the case of CABG surgery. Inquiry 33 (1996) 155-166
32. US Census Bureau. Available at: www.census.gov. Accessed May 13 2007.
33. Rosenbaum P., and Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
34. Mehta S.R., Yusuf S., Peters R.J., Bertrand M.E., Lewis B.S., Natarajan M.K., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527-533
35. Limet R., David J.L., Magotteaux P., Larock M.P., and Rigo P. Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study. J Thorac Cardiovasc Surg 94 (1987) 773-783
36. Muller C., Buttner H.J., Petersen J., and Roskamm H. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 101 (2000) 590-593
37. Harker L.A., Marzec U.M., Kelly A.B., Chronos N.R., Sundell I.B., Hanson S.R., et al. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation 98 (1998) 2461-2469
38. Yusuf S., Mehta S.R., Zhao F., Gersh B.J., Commerford P.J., Blumenthal M., et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 107 (2003) 966-972
39. Kulik A., Le M.M., Wells G.A., Mesana T.G., and Ruel M. The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]. Curr Control Trials Cardiovasc Med 6 (2005) 15
40. Straka Z., Widimsky P., Jirasek K., Stros P., Votava J., Vanek T., et al. Off-pump versus on-pump coronary surgery: final results from a prospective randomized study PRAGUE-4. Ann Thorac Surg 77 (2004) 789-793
41. Williams M.L., Muhlbaier L.H., Schroder J.N., Hata J.A., Peterson E.D., Smith P.K., et al. Risk-adjusted short- and long-term outcomes for on-pump versus off-pump coronary artery bypass surgery. Circulation 112 9 Suppl (2005) I366-I370
42. Cleveland Jr. J.C., Shroyer A.L., Chen A.Y., Peterson E., and Grover F.L. Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. Ann Thorac Surg 72 (2001) 1282-1288
43. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey Jr. D.E., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 50 (2007) e1-e57
44. Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Halasyamani L.K., et al. 2007 focused update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 117 (2008) 296-329